| Trial ID: | L0978 |
| Source ID: | NCT00546455
|
| Associated Drug: |
Fenretinide
|
| Title: |
Phase 2 Study of the Assessment of the Insulin Sensitizing Activity of Fenretinide in Subjects With Insulin Resistance With BMI >30Kg/m2, and Liver Inflammation Related to Non-alcoholic Fatty Liver
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Obesity;Insulin Resistance
|
| Interventions: |
Drug: Fenretinide;Drug: Placebo
|
| Outcome Measures: |
Assessment of the effect on insulin resistanceAssessment of the biochemical response in cholesterol, glucose and related blood tests.
|
| Sponsor/Collaborators: |
University of California, San Diego
|
| Gender: |
All
|
| Age: |
18 Years65 Years
|
| Phases: |
Phase 2
|
| Enrollment: |
120
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
|
| Start Date: |
17/10/2007
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
19 February 2015
|
| Locations: |
United States
|
| URL: |
http://clinicaltrials.gov/show/NCT00546455
|
